摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(4R,4aS,6R,10R,12S,12aR)-4-(tert-Butyldimethylsiloxy)dodecahydro-6-hydroxy-12-(methoxymethoxy)-12a,13,13-trimethyl-6,10-methanobenzocyclodecen-7(1H)-one | 150931-01-4

中文名称
——
中文别名
——
英文名称
(4R,4aS,6R,10R,12S,12aR)-4-(tert-Butyldimethylsiloxy)dodecahydro-6-hydroxy-12-(methoxymethoxy)-12a,13,13-trimethyl-6,10-methanobenzocyclodecen-7(1H)-one
英文别名
——
(4R,4aS,6R,10R,12S,12aR)-4-(tert-Butyldimethylsiloxy)dodecahydro-6-hydroxy-12-(methoxymethoxy)-12a,13,13-trimethyl-6,10-methanobenzocyclodecen-7(1H)-one化学式
CAS
150931-01-4
化学式
C26H48O5Si
mdl
——
分子量
468.75
InChiKey
CIMIBLRFZLNYMI-ZLTVSTEPSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    500.2±50.0 °C(predicted)
  • 密度:
    1.04±0.1 g/cm3(Temp: 20 °C; Press: 760 Torr)(predicted)

反应信息

  • 作为反应物:
    描述:
    (4R,4aS,6R,10R,12S,12aR)-4-(tert-Butyldimethylsiloxy)dodecahydro-6-hydroxy-12-(methoxymethoxy)-12a,13,13-trimethyl-6,10-methanobenzocyclodecen-7(1H)-one双(三甲基硅烷基)氨基钾2-(Phenylsulfonyl)-3-phenyloxaziridin 作用下, 以 四氢呋喃甲苯 为溶剂, 以82%的产率得到(4R,4aS,6R,10S,12S,12aR)-4-(tert-Butyldimethylsiloxy)-1,2,4,4a,5,6,10,11,12,12a-decahydro-6,8-dihydroxy-12-(methoxymethoxy)-12a,13,13-trimethyl-6,10-methanobenzocyclodecen-7(1H)-one
    参考文献:
    名称:
    A-Ring oxygenation studies in bridgehead hydroxyl-substituted trans-tricyclo[9.3.1.03,8]pentadecan-14-one congeners of taxol
    摘要:
    The ready availability of 5 has prompted examination of a convenient means for carbonyl transposition in its A-ring. Attempts to implement such chemistry directly on 5 and its silyl-protected derivative suffer from a kinetic proclivity for transannular capture of the enolate anion. This undesirable process was circumvented by reduction of the C9 carbonyl following conversion to silyl enol ether 8. Once the resulting 9alpha-alcohol was protected as its MOM ether, the enolates of 10a and 10b could be efficiently oxygenated at C13 by treatment with the Davis sulfonyl oxaziridine despite severe steric congestion in that locale. The resultant alpha-alcohol 11a could be epimerized to the 13beta-isomer by exposure to potassium hexamethyldisilazide. Remarkably, 11a is prone to autoxidation, although the yield of diketone 12 is capricious. A preferred route to this key intermediate involves periodinane oxidation of 11a. Reduction of 12 and its O-silylated derivative has provided the targeted compounds 15 and 16, respectively. The conformational features of various intermediates are discussed in the light of NMR studies and MM2 calculations.
    DOI:
    10.1021/jo00070a037
  • 作为产物:
    描述:
    (4R,4aS,6R,10R,12S,12aR)-4-(tert-Butyldimethylsiloxy)-1,2,3,4,4a,5,6,9,10,11,12a-dodecahydro-12-(methoxymethoxy)-12a,13,13-trimethyl-6,7-bis(trimethylsiloxy)-6,10-methanobenzocyclodecene 在 盐酸 作用下, 以 四氢呋喃 为溶剂, 反应 16.0h, 以95%的产率得到(4R,4aS,6R,10R,12S,12aR)-4-(tert-Butyldimethylsiloxy)dodecahydro-6-hydroxy-12-(methoxymethoxy)-12a,13,13-trimethyl-6,10-methanobenzocyclodecen-7(1H)-one
    参考文献:
    名称:
    A-Ring oxygenation studies in bridgehead hydroxyl-substituted trans-tricyclo[9.3.1.03,8]pentadecan-14-one congeners of taxol
    摘要:
    The ready availability of 5 has prompted examination of a convenient means for carbonyl transposition in its A-ring. Attempts to implement such chemistry directly on 5 and its silyl-protected derivative suffer from a kinetic proclivity for transannular capture of the enolate anion. This undesirable process was circumvented by reduction of the C9 carbonyl following conversion to silyl enol ether 8. Once the resulting 9alpha-alcohol was protected as its MOM ether, the enolates of 10a and 10b could be efficiently oxygenated at C13 by treatment with the Davis sulfonyl oxaziridine despite severe steric congestion in that locale. The resultant alpha-alcohol 11a could be epimerized to the 13beta-isomer by exposure to potassium hexamethyldisilazide. Remarkably, 11a is prone to autoxidation, although the yield of diketone 12 is capricious. A preferred route to this key intermediate involves periodinane oxidation of 11a. Reduction of 12 and its O-silylated derivative has provided the targeted compounds 15 and 16, respectively. The conformational features of various intermediates are discussed in the light of NMR studies and MM2 calculations.
    DOI:
    10.1021/jo00070a037
点击查看最新优质反应信息

同类化合物

(5β,6α,8α,10α,13α)-6-羟基-15-氧代黄-9(11),16-二烯-18-油酸 (3S,3aR,8aR)-3,8a-二羟基-5-异丙基-3,8-二甲基-2,3,3a,4,5,8a-六氢-1H-天青-6-酮 (2Z)-2-(羟甲基)丁-2-烯酸乙酯 (2S,4aR,6aR,7R,9S,10aS,10bR)-甲基9-(苯甲酰氧基)-2-(呋喃-3-基)-十二烷基-6a,10b-二甲基-4,10-dioxo-1H-苯并[f]异亚甲基-7-羧酸盐 (1aR,4E,7aS,8R,10aS,10bS)-8-[((二甲基氨基)甲基]-2,3,6,7,7a,8,10a,10b-八氢-1a,5-二甲基-氧杂壬酸[9,10]环癸[1,2-b]呋喃-9(1aH)-酮 (+)顺式,反式-脱落酸-d6 龙舌兰皂苷乙酯 龙脑香醇酮 龙脑烯醛 龙脑7-O-[Β-D-呋喃芹菜糖基-(1→6)]-Β-D-吡喃葡萄糖苷 龙牙楤木皂甙VII 龙吉甙元 齿孔醇 齐墩果醛 齐墩果酸苄酯 齐墩果酸甲酯 齐墩果酸溴乙酯 齐墩果酸二甲胺基乙酯 齐墩果酸乙酯 齐墩果酸3-O-alpha-L-吡喃鼠李糖基(1-3)-beta-D-吡喃木糖基(1-3)-alpha-L-吡喃鼠李糖基(1-2)-alpha-L-阿拉伯糖吡喃糖苷 齐墩果酸 beta-D-葡萄糖酯 齐墩果酸 beta-D-吡喃葡萄糖基酯 齐墩果酸 3-乙酸酯 齐墩果酸 3-O-beta-D-葡吡喃糖基 (1→2)-alpha-L-吡喃阿拉伯糖苷 齐墩果酸 齐墩果-12-烯-3b,6b-二醇 齐墩果-12-烯-3,24-二醇 齐墩果-12-烯-3,21,23-三醇,(3b,4b,21a)-(9CI) 齐墩果-12-烯-3,21,23-三醇,(3b,4b,21a)-(9CI) 齐墩果-12-烯-3,11-二酮 齐墩果-12-烯-2α,3β,28-三醇 齐墩果-12-烯-29-酸,3,22-二羟基-11-羰基-,g-内酯,(3b,20b,22b)- 齐墩果-12-烯-28-酸,3-[(6-脱氧-4-O-b-D-吡喃木糖基-a-L-吡喃鼠李糖基)氧代]-,(3b)-(9CI) 齐墩果-12-烯-28-酸,3,7-二羰基-(9CI) 齐墩果-12-烯-28-酸,3,21,29-三羟基-,g-内酯,(3b,20b,21b)-(9CI) 鼠特灵 鼠尾草酸醌 鼠尾草酸 鼠尾草酚酮 鼠尾草苦内脂 黑蚁素 黑蔓醇酯B 黑蔓醇酯A 黑蔓酮酯D 黑海常春藤皂苷A1 黑檀醇 黑果茜草萜 B 黑五味子酸 黏黴酮 黏帚霉酸